01 8Uptravi
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 1,093
2019 Revenue in Millions : 819
Growth (%) : 33
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 1,237
2020 Revenue in Millions : 1,093
Growth (%) : 13
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 1,322
2021 Revenue in Millions : 1,237
Growth (%) : 7
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 1,582
2022 Revenue in Millions : 1,322
Growth (%) : 20
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2016 Revenue in Millions : 243
2015 Revenue in Millions : Not Reported
Growth (%) : New Launch
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2017 Revenue in Millions : 263
2016 Revenue in Millions : 259
Growth (%) : 2
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2018 Revenue in Millions : 663
2017 Revenue in Millions : 263
Growth (%) : 152%
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 819
2018 Revenue in Millions : 663
Growth (%) : 24
LOOKING FOR A SUPPLIER?